It could help in temporarily aiding the symptoms and provide relief but its effect might not be long-term
These early studies confirmed the once-weekly dosing feasibility and identified the gastrointestinal side effectsprimarily nausea, vomiting, and diarrheathat would become characteristic of GLP-1 receptor agonist therapy
With the inclusion of FSA and HSA options to manage out-of-pocket costs, financial ease is within reach for FDA-approved medication recipients
Lets break it down in a clear, practical way
Holzapfel C, Cresswell L, Ahern AL, Fuller NR, Eberhard M, Stoll J, et al
Do not use Wegovy, Ozempic, or Compounded Liraglutide + B12 if you or any of your family have ever had a type of thyroid cancer called medullary thyroid carcinoma (MTC), or if you have an endocrine system condition called multiple endocrine neoplasia syndrome type 2 (MEN 2)